Navigation Links
ValGenesis Inc. Successfully Completes ISO 9001:2008 Surveillance Audit

FREMONT, Calif., April 22, 2016 /PRNewswire/ -- ValGenesis Inc., the market leader in Enterprise Validation Lifecycle Management Solutions (VLMS) today announced that it had successfully completed the ISO 9001:2008 surveillance audit focused on the development, implementation and maintenance of its software and services.

Logo -

Certification to ISO 9001 requires an accredited third party auditing organization to thoroughly review the company's internal quality management system processes. Third party auditing ensures that the company is capable of consistently delivering products and services that meet customers' requirements and expectations.   The completion of the ISO 9001:2008 Surveillance Audit clearly demonstrates that ValGenesis is vigilant in its commitment to the highest quality and standards.

Since 2012, the ValGenesis organization has successfully continued its ISO 9001:2008 certification.   In support of its efforts, ValGenesis has leveraged its own validation lifecycle management system platform to dynamically manage its corporate quality management system. ValGenesis Lifecycle Management Solutions (VLMS) has been adopted to manage and automate the software development lifecycle as well as the validation lifecycle and quality management processes.

"Since 2012, the maintenance of ISO 9001:2008 certification has demonstrated ValGenesis's commitment and structured approach to the development, implementation and maintenance of its software and services," said Siva Samy, ValGenesis's Chief Product Strategist. "As a global leader in the validation lifecycle management space, it is imperative that ValGenesis works diligently to improve the internal processes so as to provide the highest quality products and services to its customers. By achieving the ISO 9001:2008 standards certification, ValGenesis ensures that ongoing measurements and improvements are part of its process, allowing the company to maintain its commitment to the highest level of customer satisfaction, while also protecting its customers' investment."

About ValGenesis
ValGenesis, Inc. is the creator of an innovative software platform serving as the foundation for managing compliance-based validation activities in Life Sciences companies. ValGenesis, Inc. provides the first enterprise application to manage the corporate validation lifecycle process. As the only system for managing validation execution and approval 100% electronically, ValGenesis was selected by an industry peer review committee to receive the Parenteral Drug Association (PDA) New Innovative Technology Award. The solution is fully compliant with U.S. FDA 21 CFR Part 11 and Annex 11 requirements. For more information, visit

Media Contact:
Nancy DeFilippis
510-445-0505 x1025

To view the original version on PR Newswire, visit:

SOURCE ValGenesis Inc.
Copyright©2016 PR Newswire.
All rights reserved

Related biology technology :

1. ValGenesis Inc. Successfully Completes Service Organization Controls 2 (SOC 2) Report under AT Section 101
2. Allakos Successfully Completes Dosing in Phase 1 Clinical Trial of AK001 and Announces Expansion of its Executive Team
3. ProMetics plasminogen drug successfully used to treat plasminogen deficient infant in critical condition
4. Brain State Technologies Successfully Produces Wearable Devices for Sleep and Performance Enhancement Under Contract with US Army Research Office
5. Dallas-Fort Worth Stem Cell Researchers Use Amniotic Tissue To Successfully Treat Non-Healing Surgical Wound
6. Diabetes Research Institute Successfully Transplants First Patient In Pilot BioHub Trial
7. Regen BioPharma, Inc. BORIS Gene Silencing Technology Successfully Utilized by Independent Researchers to Kill Breast Cancer and Colon Cancer Stem Cells
8. VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product
9. Crystal Diagnostics Successfully Detects Deadly Ebola Virus in less than 20 Minutes
10. Vaccine Specialist AFFiRiS AG Successfully Completes Financing Round
11. University of Maryland Researchers Successfully Produce Genome-edited Pigs Using Revolutionary Technology
Post Your Comments:
(Date:8/8/2019)... FRANCISCO (PRWEB) , ... August 08, 2019 , ... ... Intelligent Virtual Agents for sales and service organizations, today announced that the ... Value Leadership Award for the IVA market . Inference will officially accept the ...
(Date:8/6/2019)... ... August 06, 2019 , ... Shoreline Biome, ... to the strain level, has announced partnerships with six international distributors. , ... and research organizations in Australia, Benelux, Indonesia, Korea, Malaysia, Myanmar, New Zealand, Singapore, ...
(Date:8/4/2019)... ... ... Cirtec Medical Corporation, a strategic outsourcing partner for complex medical devices, including active implantables ... sq. ft. manufacturing facility in the Coyol free zone, located in Alajuela, Costa ... to be fully operational by the end of the year, will be the company’s ...
(Date:7/23/2019)... (PRWEB) , ... July 22, 2019 , ... ... biotech companies with best-in-class services in the fields of 3D tissue imaging ... machine learning , Visikol initially started back in 2013 as a products company. ...
Breaking Biology Technology:
(Date:8/29/2019)... ... , ... Lajollacooks4u has expanded its team as it gears up for a ... seen record growth in 2019, having hosted a multitude of team-building events and cooking ... visited the company’s La Jolla-based venue, and Lajollacooks4u has worked hard to accommodate the ...
(Date:8/27/2019)... ... 2019 , ... Shoreline Biome , a microbiome research company that develops ... as its CEO and Karen Woodward as its VP of Business Development. , ... its products and expand the company’s sales worldwide. , Prior to joining Shoreline Biome, ...
(Date:8/27/2019)... ... August 27, 2019 , ... Ambry Genetics ... genetic testing guidelines. In the largest cohort study of its kind, Ambry presents ... patients. , Clinicians use guidelines to inform decisions about which patients should ...
Breaking Biology News(10 mins):